Lappe Mark 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Lappe Mark（CIK 1366074）在 1 家公司共报告 10 笔 SEC Form 4 内部人交易（最近一笔 2026-09-28）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-28 | Inhibrx Biosciences, Inc. (INBX) | Chief Executive Officer | 买入 | 3,324 | $328,630 |
| 2026-09-28 | Inhibrx Biosciences, Inc. (INBX) | Chief Executive Officer | 买入 | 2,176 | $216,727 |
| 2026-09-28 | Inhibrx Biosciences, Inc. (INBX) | Chief Executive Officer | 买入 | 1,500 | $148,320 |
| 2026-09-28 | Inhibrx Biosciences, Inc. (INBX) | Chief Executive Officer | 买入 | 3,000 | $305,106 |
| 2026-09-08 | Inhibrx Biosciences, Inc. (INBX) | Chief Executive Officer | 买入 | 5,895 | $585,343 |
| 2026-09-08 | Inhibrx Biosciences, Inc. (INBX) | Chief Executive Officer | 买入 | 6,605 | $664,719 |
| 2026-09-08 | Inhibrx Biosciences, Inc. (INBX) | Chief Executive Officer | 买入 | 1,100 | $117,836 |
| 2026-09-08 | Inhibrx Biosciences, Inc. (INBX) | Chief Executive Officer | 买入 | 500 | $54,118 |
| 2026-09-08 | Inhibrx Biosciences, Inc. (INBX) | Chief Executive Officer | 买入 | 1,219 | $136,382 |
| 2026-09-08 | Inhibrx Biosciences, Inc. (INBX) | Chief Executive Officer | 买入 | 9,681 | $1.1M |
来源：SEC Form 4 申报文件 · 截至 2026-09-28